Supplementation with selenium-enriched yeast attenuates brain metastatic growth

Nutrition and Cancer

Volumn 65, Issue 4, 2013, Pages 563-570

  Wrobel, Jagoda K ^a   Seelbach, Melissa J ^b   Chen, Lei ^c   Power, Ronan F ^d   Toborek, Michal ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Alltech   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; LUCIFERIN; SELENOMETHIONINE; SODIUM SELENITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BIOLUMINESCENCE; BRAIN BLOOD VESSEL; BRAIN METASTASIS; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; MALE; MEASUREMENT; MELANOMA CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; YEAST;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; BRAIN NEOPLASMS; CELL MOVEMENT; DIETARY SUPPLEMENTS; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SELENIUM; YEAST, DRIED;

EID: 84877974311     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.775315     Document Type: Article

References (46)

1. Nguyen, D X, Bos, P D, and, Massague, J. 2009. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer, 9: 274-284.
2. Steeg, P S. 2006. Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med, 12: 895-904.
3. Fidler, I J, Balasubramanian, K, Lin, Q, Kim, S W, and, Kim, S J. 2010. The brain microenvironment and cancer metastasis. Mol Cells, 30: 93-98.
4. Chambers, A F, Groom, A C, and, MacDonald, I C. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2: 563-572.
5. Fidler, I J. 2003. The pathogenesis of cancer metastasis: The seed and soil hypothesis revisited. Nat Rev Cancer, 3: 453-458.
6. Hu, G, Kang, Y, and, Wang, X F. 2009. From breast to the brain: Unraveling the puzzle of metastasis organotropism. J Mol Cell Biol, 1: 3-5.
7. Kang, Y. 2006. New tricks against an old foe: Molecular dissection of metastasis tissue tropism in breast cancer. Breast Dis, 26: 129-138.
8. Weil, R J, Palmieri, D C, Bronder, J L, Stark, A M, and, Steeg, P. 2005. Breast cancer metastasis to the central nervous system. Am J Pathol, 167: 913-920.
9. Kyritsis, A P, Markoula, S, and, Levin, V A. 2012. A systematic approach to the management of patients with brain metastases of known or unknown primary site. Cancer Chemother Pharmacol, 69: 1-13.
10. Nussbaum, E S, Djalilian, H R, Cho, K H, and, Hall, W A. 1996. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer, 78: 1781-1788.
11. Makrilia, N, Kollias, A, Manolopoulos, L, and, Syrigos, K. 2009. Cell adhesion molecules: Role and clinical significance in cancer. Cancer Invest, 27: 1023-1037.
12. Choi, W, Eum, S Y, Lee, Y W, Hennig, B, Robertson, L W. 2003. PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis. Toxicol Sci, 75: 47-56.
13. Chen, L M, Kuo, C H, Lai, T Y, Lin, Y M, Su, C C. 2011. RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. J Cell Biochem, 112: 933-941.
14. Eum, S Y, Andras, I, Hennig, B, and, Toborek, M. 2009. NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of cell adhesion molecules in human brain endothelial cells. Toxicol Appl Pharmacol, 240: 299-305.
15. Sumagin, R, and, Sarelius, I H. 2007. A role for ICAM-1 in maintenance of leukocyte-endothelial cell rolling interactions in inflamed arterioles. Am J Physiol Heart Circ Physiol, 293: H2786-H2798.
16. Sipos, E, Chen, L, Andras, I E, Wrobel, J, Zhang, B. 2012. Proinflammatory adhesion molecules facilitate polychlorinated biphenyl-mediated enhancement of brain metastasis formation. Toxicol Sci., 126: 362-371.
17. Yamagata, K, Miyashita, A, Matsufuji, H, and, Chino, M. 2010. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. J Nutr Biochem, 21: 116-124.
18. Fritz, H, Kennedy, D, Fergusson, D, Fernandes, R, Cooley, K. 2011. Selenium and lung cancer: A systematic review and meta analysis. PLoS One, 6. e26259
19. Rayman, M P. 2000. The importance of selenium to human health. Lancet, 356: 233-241.
20. Lovell, M A, Xiong, S, Lyubartseva, G, and, Markesbery, W R. 2009. Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radic Biol Med, 46: 1527-1533.
21. Connolly, C D, Power, R F, and, Hynes, M J. 2003. Determination of selenium in animal feed by hydride generation AAS: Validation of analytical method. Atomic Spectroscopy, 24: 115-117.
22. Chen, L, Swartz, K R, and, Toborek, M. 2009. Vessel microport technique for applications in cerebrovascular research. J Neurosci Res, 87: 1718-1727.
23. Rayman, M P. 2012. Selenium and human health. Lancet, 379: 1256-1268.
24. Hardy, G, Hardy, I, and, Manzanares, W. 2012. Selenium supplementation in the critically ill. Nutr Clin Pract, 27: 21-33.
25. Zhan, X, Qie, Y, Wang, M, Li, X, and, Zhao, R. 2011. Selenomethionine: An effective selenium source for sow to improve Se distribution, antioxidant status, and growth performance of pig offspring. Biol Trace Elem Res, 142: 481-491.
26. Thomson, C D. 2004. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr, 58: 391-402.
27. Letavayova, L, Vlckova, V, and, Brozmanova, J. 2006. Selenium: From cancer prevention to DNA damage. Toxicology, 227: 1-14.
28. Suryo Rahmanto, A, and, Davies, M J. 2011. Catalytic activity of selenomethionine in removing amino acid, peptide, and protein hydroperoxides. Free Radic Biol Med, 51: 2288-2299.
29. Schrauzer, G N. 2001. Nutritional selenium supplements: Product types, quality, and safety. J Am Coll Nutr, 20: 1-4.
30. Shiobara, Y, Yoshida, T, and, Suzuki, K T. 1998. Effects of dietary selenium species on Se concentrations in hair, blood, and urine. Toxicol Appl Pharmacol, 152: 309-314.
31. Letavayova, L, Vlasakova, D, Spallholz, J E, Brozmanova, J, and, Chovanec, M. 2008. Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae. Mutat Res, 638: 1-10.
32. Brozmanova, J, Manikova, D, Vlckova, V, and, Chovanec, M. 2010. Selenium: A double-edged sword for defense and offence in cancer. Arch Toxicol, 84: 919-938.
33. Ganther, H E. 1971. Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase. Biochemistry, 10: 4089-4098.
34. Griffiths, J C, Matulka, R A, and, Power, R. 2006. Genotoxicity studies on Sel-Plex, a standardized, registered high-selenium yeast. Int J Toxicol, 25: 477-485.
35. Rayman, M P. 2004. The use of high-selenium yeast to raise selenium status: How does it measure up?. Br J Nutr, 92: 557-573.
36. Burk, R F, and, Levander, O A. 2006. " Selenium ". In Modern Nutrition in Health and Disease, 10th ed, Edited by: Shils, M E, Shike, M, Ross, A C, Caballero, B and Cousins, R J. 322-323. Baltimore: Lippincott Williams & Wilkins.
37. Yan, L, and, DeMars, L C. 2012. Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. Int J Cancer, 131: 1260-1266.
38. Yan, L, Yee, J A, McGuire, M H, and, Graef, G L. 1997. Effect of dietary supplementation of selenite on pulmonary metastasis of melanoma cells in mice. Nutr Cancer, 28: 165-169.
39. Yan, L, Yee, J A, Li, D, McGuire, M H, and, Graef, G L. 1999. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Res, 19: 1337-1342.
40. Jackson, M I, and, Combs, G F Jr. 2008. Selenium and anticarcinogenesis: Underlying mechanisms. Curr Opin Clin Nutr Metab Care, 11: 718-726.
41. Spallholz, J E. 1994. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med, 17: 45-64.
42. Ip, C. 1998. Lessons from basic research in selenium and cancer prevention. J Nutr, 128: 1845-1854.
43. Kramer, G F, and, Ames, B N. 1988. Mechanisms of mutagenicity and toxicity of sodium selenite (Na2SeO3) in Salmonella typhimurium. Mutat Res, 201: 169-180.
44. Spallholz, J E. 1997. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci, 10: 260-270.
45. Kryukov, G V, Castellano, S, Novoselov, S V, Lobanov, A V, Zehtab, O. 2003. Characterization of mammalian selenoproteomes. Science, 300: 1439-1443.
46. Gromer, S, Eubel, J K, Lee, B L, and, Jacob, J. 2005. Human selenoproteins at a glance. Cell Mol Life Sci, 62: 2414-2437.